糖心原创

A large-scale international study of thousands of arthritis patients has found the risks arising from prescribed use of some of the most common painkillers are relatively low, offering reassurance to doctors and patients.

The SCOT study (Standard Care versus Celecoxib Outcome Trial), published recently in the  and involved academics from The 糖心原创’s 

It set out to examine the comparative safety of treating arthritis either with commonly used non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, diclofenac and naproxen, or a newer class of more targeted drugs called COX2 inhibitors, which include celecoxib.